News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
233,570 Results
Type
Article (14337)
Company Profile (25)
Press Release (219207)
Multimedia
Podcasts (10)
Webinars (1)
Section
Business (72591)
Career Advice (557)
Deals (12626)
Drug Delivery (23)
Drug Development (27171)
Employer Resources (14)
FDA (5229)
Job Trends (4927)
News (118122)
Policy (9096)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
Academia (558)
Accelerated approval (6)
Allergies (50)
Alliances (11452)
ALS (42)
Alzheimer's disease (461)
Antibody-drug conjugate (ADC) (86)
Approvals (5455)
Artificial intelligence (75)
Autoimmune disease (39)
Automation (5)
Bankruptcy (94)
Best Places to Work (3724)
BIOSECURE Act (3)
Biosimilars (66)
Biotechnology (21)
Bladder cancer (57)
Brain cancer (20)
Breast cancer (249)
Cancer (1577)
Cardiovascular disease (137)
Career advice (419)
Career pathing (4)
CAR-T (72)
CDC (6)
Cell therapy (194)
Cervical cancer (12)
Clinical research (24656)
Collaboration (293)
Compensation (287)
Complete response letters (9)
COVID-19 (708)
CRISPR (24)
C-suite (103)
Cystic fibrosis (35)
Data (2384)
Depression (50)
Diabetes (186)
Diagnostics (1756)
Digital health (14)
Diversity, equity & inclusion (6)
Drug discovery (38)
Drug pricing (34)
Drug shortages (2)
Duchenne muscular dystrophy (73)
Earnings (51088)
Editorial (13)
Employer branding (4)
Employer resources (13)
Events (35952)
Executive appointments (129)
FDA (6286)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (278)
Gene editing (46)
Generative AI (5)
Gene therapy (134)
GLP-1 (311)
Government (1041)
Grass and pollen (4)
Guidances (324)
Healthcare (5301)
HIV (20)
Huntington's disease (10)
IgA nephropathy (24)
Immunology and inflammation (79)
Immuno-oncology (14)
Indications (40)
Infectious disease (785)
Inflammatory bowel disease (53)
Inflation Reduction Act (2)
Influenza (32)
Intellectual property (47)
Interviews (91)
IPO (7122)
IRA (8)
Job creations (1393)
Job search strategy (392)
JPM (14)
Kidney cancer (10)
Labor market (28)
Layoffs (144)
Leadership (3)
Legal (2187)
Liver cancer (24)
Longevity (2)
Lung cancer (270)
Lymphoma (137)
Machine learning (6)
Management (1)
Manufacturing (141)
MASH (64)
Medical device (3794)
Medtech (3809)
Mergers & acquisitions (5839)
Metabolic disorders (420)
Multiple sclerosis (64)
NASH (6)
Neurodegenerative disease (90)
Neuropsychiatric disorders (39)
Neuroscience (834)
Neurotech (1)
NextGen: Class of 2026 (1346)
Non-profit (953)
Now hiring (6)
Obesity (172)
Opinion (52)
Ovarian cancer (44)
Pain (60)
Pancreatic cancer (66)
Parkinson's disease (66)
Patents (81)
Patient recruitment (99)
Peanut (18)
People (11443)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase 1 (6441)
Phase 2 (10278)
Phase 3 (9341)
Pipeline (2608)
Policy (32)
Postmarket research (992)
Preclinical (2223)
Press Release (12)
Prostate cancer (96)
Psychedelics (9)
Radiopharmaceuticals (95)
Rare diseases (231)
Real estate (1420)
Recruiting (5)
Regulatory (7051)
Reports (20)
Research institute (509)
Resumes & cover letters (95)
Rett syndrome (11)
RNA editing (2)
RSV (27)
Schizophrenia (62)
Series A (37)
Series B (30)
Sickle cell disease (31)
Special edition (11)
Spinal muscular atrophy (46)
Sponsored (8)
Startups (808)
Stomach cancer (3)
Supply chain (17)
Tariffs (16)
The Weekly (10)
Vaccines (255)
Venture capital (24)
Weight loss (126)
Women's health (19)
Worklife (4)
Date
Today (34)
Last 7 days (143)
Last 30 days (566)
Last 365 days (9396)
2026 (998)
2025 (9660)
2024 (10901)
2023 (12392)
2022 (15248)
2021 (16750)
2020 (15561)
2019 (11763)
2018 (8826)
2017 (8376)
2016 (7143)
2015 (9021)
2014 (27505)
2013 (35250)
2012 (5392)
2011 (5752)
2010 (5166)
Location
Africa (231)
Alabama (18)
Arizona (84)
Arkansas (5)
Asia (14237)
Australia (2220)
California (3362)
Canada (936)
China (354)
Colorado (153)
Connecticut (160)
Delaware (118)
Europe (34775)
Florida (463)
Georgia (120)
Idaho (13)
Illinois (224)
India (21)
Indiana (213)
Iowa (1)
Japan (185)
Kansas (32)
Kentucky (11)
Louisiana (11)
Maine (32)
Maryland (415)
Massachusetts (2343)
Michigan (105)
Minnesota (179)
Mississippi (3)
Missouri (25)
Montana (8)
Nebraska (1)
Nevada (38)
New Hampshire (32)
New Jersey (1150)
New Mexico (1)
New York (1040)
North Carolina (382)
Northern California (1711)
Ohio (70)
Oklahoma (5)
Oregon (6)
Pennsylvania (713)
Puerto Rico (4)
Rhode Island (6)
South America (375)
South Carolina (8)
Southern California (1340)
Tennessee (46)
Texas (462)
United States (12069)
Utah (104)
Virginia (48)
Washington D.C. (14)
Washington State (228)
West Virginia (2)
Wisconsin (23)
Wyoming (1)
233,570 Results for "14".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%
February 17, 2026
·
15 min read
Earnings
Novo Slides 14% as Early Q4 Results Predict Sales Decline for 2026
Novo Nordisk beat analyst expectations for the fourth quarter, but the result was overshadowed by softened expectations for this year.
February 3, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia
January 16, 2026
·
6 min read
Press Releases
Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX™
January 9, 2026
·
4 min read
Press Releases
PreciseOnco research consortium awarded EUR 14.9 million IHI grant to drive breakthroughs in precision cancer treatment
February 3, 2026
·
8 min read
Press Releases
Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
January 6, 2026
·
1 min read
Press Releases
Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
January 5, 2026
·
1 min read
Press Releases
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
December 16, 2025
·
16 min read
Press Releases
Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
January 7, 2026
·
1 min read
Press Releases
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
January 6, 2026
·
1 min read
1 of 23,357
Next
